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SUMMARY. Lipid-based nanocarriers were prepared by hot solvent diffusion technique. Tristearin (TS)
and/or castor oil were employed as oily phase, and Lutrol F68® or Solutol HS15® and lecithin were em-
ployed as surfactant and cosurfactant, respectively. The influence of the formulation variables on surface
charge and size of the nanocarriers and their ability to load and control the release of quercetin were in-
vestigated. Solid lipid nanoparticles, nanostructured lipid carriers, nanoemulsions, and microemulsions
(ME) were obtained depending on the formulation composition. Querecetin (QU) entrapment efficacy was
higher than 99 % for all formulations. However, drug content was greatly affected by the formulation
composition. ME exhibited the highest capacity to load QU, reaching a concentration around 1,300 times
higher than its aqueous solubility. QU release profiles exhibited biphasic kinetics for all formulations.
However, the release rate of QU was affected by the properties of the nanocarrier. 
